Fouad Namouni - Net Worth and Insider Trading
Fouad Namouni Net Worth
The estimated net worth of Fouad Namouni is at least $6 Million dollars as of 2024-11-05. Fouad Namouni is the PRESIDENT, R & D of Blueprint Medicines Corp and owns about 69,070 shares of Blueprint Medicines Corp (BPMC) stock worth over $6 Million. Details can be seen in Fouad Namouni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fouad Namouni has not made any transactions after 2024-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fouad Namouni
Fouad Namouni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fouad Namouni owns 2 companies in total, including Blueprint Medicines Corp (BPMC) , and Aprea Therapeutics Inc (APRE) .
Click here to see the complete history of Fouad Namouni’s form 4 insider trades.
Insider Ownership Summary of Fouad Namouni
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-10-03 | President & R and D |
| APRE | Aprea Therapeutics Inc | 2020-06-26 | director |
Fouad Namouni Latest Holdings Summary
Fouad Namouni currently owns a total of 1 stock. Fouad Namouni owns 69,070 shares of Blueprint Medicines Corp (BPMC) as of October 3, 2024, with a value of $6 Million.
Latest Holdings of Fouad Namouni
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-10-03 | 69,070 | 92.25 | 6,371,708 |
Holding Weightings of Fouad Namouni
Fouad Namouni Form 4 Trading Tracker
According to the SEC Form 4 filings, Fouad Namouni has made a total of 6 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 3,633 shares on October 3, 2024, which brought Fouad Namouni around $324,500.
Insider Trading History of Fouad Namouni
- 1
Fouad Namouni Trading Performance
Fouad Namouni Ownership Network
Ownership Network List of Fouad Namouni
Ownership Network Relation of Fouad Namouni
Fouad Namouni Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Fouad Namouni is the President & R and D of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include director & CEO & President Jeffrey W. Albers , Principal FAO Michael Landsittel , and Chief Commercial Officer Philina Lee .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Fouad Namouni made 3 insider transaction in Blueprint Medicines Corp (BPMC) with a net sale of 11,779. Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .
In summary, during the past 3 months, insiders sold 27,744 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 27,744 shares. During the past 18 months, 464,866 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 464,866 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Fouad Namouni Mailing Address
Above is the net worth, insider trading, and ownership report for Fouad Namouni. You might contact Fouad Namouni via mailing address: 535 Boylston St., 2nd Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
